Journal of Neuroinflammation 2024

4 papers
The 2024 edition of the Journal of Neuroinflammation features research focused on the mechanisms of neural circuit decay and the role of extracellular vesicles in inflammatory responses. A primary area of investigation involves protecting synaptic integrity, specifically through the inhibition of the STING pathway to prevent microglia-mediated synapse engulfment following stroke. Additionally, studies examine the communication between systemic and central nervous system environments, such as how macrophage-derived exosomal miR-30c-2-3p from atherosclerotic plaques influences microglial neuroinflammation via the TGF-β/SMAD2 pathway. Research themes this year also emphasize the biphasic nature of therapeutic windows and the pleiotropic toxicity associated with master regulator therapeutics. Contributions from authors including Chuanbo Qin, Dai‐Shi Tian, and Hang Zhang explore the characterization of spinal cord tissue-derived extracellular vesicles. These works collectively address the importance of temporal precision in neuroinflammatory treatments and the complex interactions between immune cells and neuronal structures during disease progression.

Top Research Directions

The 9 research directions with Journal of Neuroinflammation 2024 papers, ranked by paper count, next to 2023. Share is the fraction of the edition’s papers in the direction.

#Direction20242023Share 2024Share 20232023 rank
1Dysregulated Synaptic Pruning in Neurodevelopment and Neurodegeneration1025.0%0.0%—
2Exonuclease Resistance in Circulating RNA Biomarkers1025.0%0.0%—
3Mapping Functional Regulatory Links via Single-Cell Multi-Omics1025.0%0.0%—
4Multi-Modal Characterization of Extracellular Vesicles1025.0%0.0%—
5Post-Translational Control of Subcellular Protein Localization1025.0%0.0%—
6Reprogramming Microglial Phenotypes for Neuroprotection1025.0%0.0%—
7Restoring Synaptic Plasticity Through Structural Circuit Remodeling1025.0%0.0%—
8Temporal Windows and Stage Dependent Therapeutic Efficacy1025.0%0.0%—
9The Cellular Maturation Gap in Stem Cell Models1025.0%0.0%—

Download all directions as CSV

Institutions

Institutions credited by Journal of Neuroinflammation 2024 papers: a paper credits every institution named in its affiliations, once. 3 institutions share 2 credited papers.

#InstitutionPapersShare20232023 rank
1China Pharmaceutical University 150.0%0—
2Johns Hopkins Medicine 150.0%13
3Johns Hopkins University 150.0%11

Download all institutions as CSV

About this data

Papers. Journal of Neuroinflammation 2024 lists 4 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers. Comparisons with 2023 use shares, since the edition went from 4 to 4 papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 2 of 4 papers (50.0%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-22 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Journal of Neuroinflammation 2024”, https://lacuna.tiptreesystems.com/venue/journal-of-neuroinflammation/2024.

Top Authors

AuthorPapers
Ha-Eun Lee1
Hyunju Lee1
Ji‐Eun Kim1
Rachel S. Ehrlich1
Sascha Castro Lingl1
Sehyun Chae1
Yoo Joo Jeong1

Impactful Papers

Papers from Journal of Neuroinflammation 2024 that shaped research clusters.

Influential

Papers

Title
Characterization of spinal cord tissue-derived extracellular vesicles in neuroinflammation
Macrophage exosomal miR-30c-2-3p in atherosclerotic plaques aggravates microglial neuroinflammation during large-artery atherosclerotic stroke via TGF-β/SMAD2 pathway
STING inhibition suppresses microglia-mediated synapses engulfment and alleviates motor functional deficits after stroke
The dopamine analogue CA140 alleviates AD pathology, neuroinflammation, and rescues synaptic/cognitive functions by modulating DRD1 signaling or directly binding to Abeta